Terumo BCT receives $17.4M contract from BARDA for blood study

Terumo BCT receives $17.4M contract from BARDA for blood study

LAKEWOOD -- Terumo BCT , a global medical device manufacturing company, announced it has been awarded $17.4 million in initial funding from the Biomedical Advanced Research and Development... Read More

Thursday June 23, 2016 0 comments Tags: Terumo BCT, Lakewood, BARDA, Mirasol Pathogen Reduction Technology, Ray Goodrich